Search results
Urine Tests Could Be 'Enormous Step' in Diagnosing Cancer
Medscape· 6 days agoThe next frontier in cancer detection could be the humble urine test. Emerging science suggests that...
What Foamy Pee Can Tell You About Your Health, According to a Urologist
PopSugar· 3 days ago"Foamy urine isn't always a big deal, and it can happen when you pee really hard or when you're...
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further...
WJTV Jackson· 2 days agoIn the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein< ...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
KOLR - KSFX Ozarks· 2 days agoPatients treated with Fabhalta in addition to supportive care achieved a 35.1% (p=0.0014) reduction in proteinuria (as measured by 24-hour urine protein ...
New Test May Be Able To Assess the Risk for Preeclampsia As Early as the First Trimester
Parents· 5 days agoIf you are pregnant or expecting, you have likely heard of preeclampsia, a condition affecting 2%-8%...
Mom, 32, had a life-threatening pregnancy complication. Doctors dismissed the signs for weeks
TODAY via Yahoo News· 3 days agoOne day, after listening to a pregnancy podcast, she got a hunch about what might be wrong. Her...
Semaglutide may protect kidney function in individuals with overweight or obesity and cardiovascular...
Medical Xpress· 1 day agoExperts believe the study's results offer hope for those affected by obesity, a condition known to exacerbate the risk of kidney function decline and macroalbuminuria (abnormal amounts of the ...
Don't Miss the Dx: Unexplained Renal Symptoms in Young Adult
Medscape· 7 days agoLearn more with this brief guide to the presentation, differential diagnosis, and management of this...
New technique detects novel biomarkers for kidney diseases with nephrotic syndrome
Medical Xpress· 1 day agoUsing a hybrid technique, researchers identified anti-nephrin autoantibodies as a reliable biomarker for tracking disease progression, opening new avenues for personalized treatment approaches ...
Novartis to seek approvals in two rare kidney diseases after positive Phase 3 trials
Endpoints News· 2 days agoNovartis is building out its rare kidney disease portfolio with two batches of Phase 3 data at the...